U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07070115) titled 'Evaluating Clinical Hiatal Hernia Outcomes Using OviTex(R)' on July 03.
Brief Summary: This study will evaluate hiatal hernia recurrence rate and post-operative complications following the use of OviTex Core Resorbable or OviTex 1S Resorbable.
Study Start Date: July 21
Study Type: INTERVENTIONAL
Condition:
Hiatal Hernia
Intervention:
DEVICE: OviTex Reinforced Tissue Matrix
All study subjects will receive OviTex. All OviTex Reinforced Tissue Matrices are intended for use as a surgical mesh to reinforce or repair soft tissue where weakness exists.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tela Bio Inc
Disclaimer: Curat...